Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.4:1
Daily Buy & Sell Volume
Transactions (114)
Alkermes plc. (ALKS)
snyderman nancy lynn MD — Director
Shares
44,472
Price
$50.35
Total Value
$2.24M
Shares Held After
15,395
% of Holdings
74.3%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$48.58
Total Value
$98.81K
Shares Held After
225,456
% of Holdings
0.9%
Alkermes plc. (ALKS)
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Shares
9,000
Price
$48.58
Total Value
$437.22K
Shares Held After
69,389
% of Holdings
11.5%
PRECIGEN, INC. (PGEN)
Shah Rutul R — Chief Operating Officer
Shares
33,772
Price
$6.50
Total Value
$219.52K
Shares Held After
497,751
% of Holdings
6.4%
Contineum Therapeutics, Inc. (CTNM)
Stengone Carmine N. — Director
Shares
2,500
Price
$16.01
Total Value
$40.03K
Shares Held After
17,217
% of Holdings
12.7%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
16,589
Price
$23.05
Total Value
$382.36K
Shares Held After
9,110
% of Holdings
64.6%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
8,003
Price
$4.80
Total Value
$38.41K
Shares Held After
722,419
% of Holdings
1.1%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
25,000
Price
$4.98
Total Value
$124.54K
Shares Held After
714,416
% of Holdings
3.5%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
3,300
Price
$4.98
Total Value
$16.42K
Shares Held After
689,416
% of Holdings
0.5%
Entrada Therapeutics, Inc. (TRDA)
5AM Ventures V, L.P. — 10% Owner
Shares
1,718
Price
$6.85
Total Value
$11.77K
Shares Held After
2,846,592
% of Holdings
0.1%
Entrada Therapeutics, Inc. (TRDA)
PARMAR KUSH — Director
Shares
1,718
Price
$6.85
Total Value
$11.77K
Shares Held After
2,846,592
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
238
Price
$522.88
Total Value
$124.44K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
282
Price
$521.52
Total Value
$147.07K
Shares Held After
324,681
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,517
Price
$520.80
Total Value
$790.06K
Shares Held After
324,963
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,627
Price
$520.12
Total Value
$1.37M
Shares Held After
326,480
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,266
Price
$519.06
Total Value
$657.12K
Shares Held After
329,107
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,215
Price
$518.00
Total Value
$629.37K
Shares Held After
330,373
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,133
Price
$516.94
Total Value
$585.70K
Shares Held After
331,588
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
857
Price
$515.84
Total Value
$442.07K
Shares Held After
332,721
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
365
Price
$514.82
Total Value
$187.91K
Shares Held After
333,578
% of Holdings
0.1%
ProQR Therapeutics N.V. (PRQR)
de Boer Daniel Anton — Director
Shares
200,000
Price
$1.77
Total Value
$353.96K
Shares Held After
500,000
% of Holdings
40.0%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
5,000
Price
$3.47
Total Value
$17.35K
Shares Held After
657,000
% of Holdings
0.8%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
24,944
Price
$9.93
Total Value
$247.69K
Shares Held After
17,329,570
% of Holdings
0.1%
IONIS PHARMACEUTICALS INC (IONS)
Hayden Michael R — Director
Shares
5,000
Price
$51.60
Total Value
$258.00K
Shares Held After
24,000
% of Holdings
20.8%
PRECIGEN, INC. (PGEN)
Thomasian Harry Jr. — Chief Financial Officer
Shares
100,000
Price
$6.06
Total Value
$606.00K
Shares Held After
254,535
% of Holdings
28.2%
Adaptive Biotechnologies Corp (ADPT)
BOBULSKY SUSAN — Chief Commercial Officer, MRD
Shares
1,299
Price
$24.00
Total Value
$31.18K
Shares Held After
399,989
% of Holdings
0.3%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
77,850
Price
$4.96
Total Value
$385.79K
Shares Held After
686,116
% of Holdings
11.3%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
100,000
Price
$4.90
Total Value
$490.00K
Shares Held After
608,266
% of Holdings
16.4%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
25,000
Price
$4.81
Total Value
$120.34K
Shares Held After
508,266
% of Holdings
4.9%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
20,000
Price
$5.00
Total Value
$100.00K
Shares Held After
483,266
% of Holdings
4.1%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
20,000
Price
$5.00
Total Value
$100.00K
Shares Held After
463,266
% of Holdings
4.3%
NextCure, Inc. (NXTC)
ADAR1 Capital Management, LLC — 10% Owner
Shares
50,000
Price
$4.97
Total Value
$248.62K
Shares Held After
443,266
% of Holdings
11.3%
Protagenic Therapeutics, Inc.\new (PTIX)
ARMEN GARO H — Director
Shares
26,291
Price
$0.18
Total Value
$4.81K
Shares Held After
26,291
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
1,044
Price
$323.69
Total Value
$337.93K
Shares Held After
0
% of Holdings
100.0%
Entrada Therapeutics, Inc. (TRDA)
5AM Ventures V, L.P. — 10% Owner
Shares
114,756
Price
$6.93
Total Value
$795.26K
Shares Held After
2,848,310
% of Holdings
3.9%
Entrada Therapeutics, Inc. (TRDA)
PARMAR KUSH — Director
Shares
114,756
Price
$6.93
Total Value
$795.26K
Shares Held After
2,848,310
% of Holdings
3.9%
BridgeBio Pharma, Inc. (BBIO)
Apuli Maricel — Chief Accounting Officer
Shares
2,000
Price
$80.06
Total Value
$160.12K
Shares Held After
127,401
% of Holdings
1.5%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
1,001
Price
$120.67
Total Value
$120.80K
Shares Held After
16,130
% of Holdings
5.8%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
8,103
Price
$119.95
Total Value
$971.94K
Shares Held After
17,131
% of Holdings
32.1%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
4,783
Price
$118.73
Total Value
$567.91K
Shares Held After
25,234
% of Holdings
15.9%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
8,267
Price
$117.93
Total Value
$974.95K
Shares Held After
30,017
% of Holdings
21.6%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
7,089
Price
$116.96
Total Value
$829.10K
Shares Held After
38,284
% of Holdings
15.6%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
14,222
Price
$115.87
Total Value
$1.65M
Shares Held After
45,373
% of Holdings
23.9%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
15,477
Price
$114.96
Total Value
$1.78M
Shares Held After
59,595
% of Holdings
20.6%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
4,700
Price
$113.18
Total Value
$531.94K
Shares Held After
75,072
% of Holdings
5.9%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
600
Price
$110.95
Total Value
$66.57K
Shares Held After
79,772
% of Holdings
0.7%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
2,202
Price
$110.03
Total Value
$242.28K
Shares Held After
80,372
% of Holdings
2.7%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
400
Price
$108.46
Total Value
$43.38K
Shares Held After
82,574
% of Holdings
0.5%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
8,956
Price
$106.96
Total Value
$957.89K
Shares Held After
82,974
% of Holdings
9.7%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
4,200
Price
$105.54
Total Value
$443.25K
Shares Held After
91,930
% of Holdings
4.4%
Showing 1–50 of 114 transactions (page 1 of 3)